FindTrial
Sign In

Havrix™

BIOLOGICAL7 trials

Sponsors

GlaxoSmithKline

Conditions

Cervical Intraepithelial NeoplasiaHepatitis AHepatitis BInfluenzaPapillomavirus Infection

Phase 3

Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
CompletedNCT00197236
GlaxoSmithKlineHepatitis A
Start: 2003-11-11End: 2007-12-03Updated: 2018-08-20
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
CompletedNCT00316706
GlaxoSmithKlineCervical Intraepithelial Neoplasia, Papillomavirus Infection
Start: 2005-10-31End: 2009-01-31Updated: 2012-09-18
A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children
CompletedNCT01218308
GlaxoSmithKlineInfluenza
Start: 2010-12-09End: 2012-01-09Updated: 2018-08-01
A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children
CompletedNCT01379937
GlaxoSmithKlineInfluenza
Start: 2011-07-28End: 2012-10-05Updated: 2018-09-07

Phase 4

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule
CompletedNCT00289757
GlaxoSmithKlineHepatitis A
Start: 2004-01-01End: 2013-03-01Updated: 2018-07-23
Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
CompletedNCT00289731
GlaxoSmithKlineHepatitis A, Hepatitis B
Start: 2003-11-24End: 2004-12-21Updated: 2019-11-15
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule
CompletedNCT00291876
GlaxoSmithKlineHepatitis A
Start: 2004-01-01End: 2013-03-01Updated: 2017-11-29

Related Papers

Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children.
2020-07-244 citations
A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years
Human Vaccines & Immunotherapeutics2019-07-0357 citations
Assessment of Prime-boost Vaccination Using an AS03B-adjuvanted Influenza A (H5N1) Vaccine: A Randomized Trial in Children of Three to Less Than Eighteen Years of Age.
2016-02-014 citations
Long-term antibody persistence after vaccination with a 2-dose Havrix™ (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions
Vaccine2015-07-1780 citations
Long-term immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in 10- to 14-year-old girls: open 6-year follow-up of an initial observer-blinded, randomized trial.
2014-12-0117 citations
Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults.
2014-02-0744 citations
Results disclosure of papilloma vaccine studies in humans completed before January 1st, 2011.
Figshare2014-01-01
Results disclosure of papilloma vaccine studies in humans co.
Figshare2014-01-01
Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children
New England Journal of Medicine2013-12-11139 citations
Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine.
2012-02-1320 citations
Four-year follow-up of the immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine when administered to adolescent girls aged 10-14 years.
2012-02-0144 citations
Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.
2011-09-013 citations
Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
2011-08-2327 citations